Related Experiment Video
Updated: Jun 27, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a
Xavier Palomer1, David Alvarez-Guardia, Ricardo Rodríguez-Calvo
1Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, IBUB and CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)-Instituto de Salud Carlos III, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain.
Insights
Tumor necrosis factor-alpha (TNF-alpha) reduces cardiac peroxisome proliferator-activated receptor coactivator 1alpha (PGC-1alpha) expression, impacting myocardial metabolism. This downregulation may contribute to heart failure in inflammatory metabolic conditions.
Area of Science:
- Cardiovascular Biology
- Molecular Metabolism
- Inflammation Research
Background:
- Cytokine-driven inflammation is linked to cardiac hypertrophy and heart failure.
- Myocardial metabolism dysregulation is increasingly associated with cardiomyopathy.
- Tumor necrosis factor-alpha (TNF-alpha) is a key pro-inflammatory cytokine implicated in cardiac pathology.
Purpose of the Study:
- To investigate the relationship between pro-inflammatory signaling and cardiac metabolic dysfunction.
- To determine the effect of TNF-alpha on key metabolic regulators in cardiac cells.
- To elucidate the molecular mechanisms linking inflammation to altered cardiac metabolism.
Main Methods:
- Treatment of human cardiac AC16 cells with TNF-alpha.
- Analysis of peroxisome proliferator-activated receptor coactivator 1alpha (PGC-1alpha) expression.
- Studies in cardiac-specific transgenic mice overexpressing TNF-alpha.
- Investigation of signaling pathways including p38 MAPK and NF-kappaB.
- Assessment of glucose oxidation rates and key metabolic gene expression.
Main Results:
- TNF-alpha inhibited PGC-1alpha expression in AC16 cells and in the hearts of TNF-alpha transgenic mice.
- The inhibitory effect of TNF-alpha on PGC-1alpha was mediated by p38 MAPK and NF-kappaB pathways.
- PGC-1alpha downregulation led to increased glucose oxidation via reduced pyruvate dehydrogenase kinase 4 expression.
- This metabolic shift was dependent on PPAR beta/delta and ERR alpha transcription factors.
Conclusions:
- Downregulation of PGC-1alpha by TNF-alpha is a significant finding in cardiac inflammation.
- This mechanism may contribute to cardiac dysfunction and heart failure in inflammatory metabolic disorders.
- Targeting PGC-1alpha or related pathways could offer therapeutic strategies for inflammatory cardiomyopathy.
Aims:
Inflammatory responses in the heart that are driven by sustained increases in cytokines have been associated with several pathological processes, including cardiac hypertrophy and heart failure. Emerging data suggest a link between cardiomyopathy and myocardial metabolism dysregulation. To further elucidate the relationship between a pro-inflammatory profile and cardiac metabolism dysregulation, a human cell line of cardiac origin, AC16, was treated with tumour necrosis factor-alpha (TNF-alpha).
Methods And Results:
Exposure of AC16 cells to TNF-alpha inhibited the expression of peroxisome proliferator-activated receptor coactivator 1alpha (PGC-1alpha), an upstream regulator of lipid and glucose oxidative metabolism. Studies performed with cardiac-specific transgenic mice (Mus musculus) overexpressing TNF-alpha, which have been well characterized as a model of cytokine-induced cardiomyopathy, also displayed reduced PGC-1alpha expression in the heart compared with that of control mice. The mechanism by which TNF-alpha reduced PGC-1alpha expression in vitro appeared to be largely mediated via both p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways. PGC-1alpha downregulation resulted in an increase in glucose oxidation rate, which involved a reduction in pyruvate dehydrogenase kinase 4 expression and depended on the DNA-binding activity of both peroxisome proliferator-activated receptor beta/delta and estrogen-related receptor alpha transcription factors.
Conclusion:
These results point to PGC-1alpha downregulation as a potential contributor to cardiac dysfunction and heart failure in metabolic disorders with an inflammatory background.
Related Concept Videos
Cell Specific Gene Expression
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways